Decreased D2-40 and increased p16INK4A immunoreactivities correlate with higher grade of cervical intraepithelial neoplasia

Diagnostic Pathology

Volumn 6, Issue 1, 2011, Pages

  Han, Hongxiu ^a,b   Yang, Yan ^b   Lu, Zhouping ^b   He, Qizhi ^b   Lin, Zhenhua ^c  

^a School of Medicine   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c YANBIAN UNIVERSITY   (China)

Author keywords

Cervical intraepithelial neoplasia; D2 40; Immunohistochemistry; P16INK4A

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DIAGNOSTIC AGENT; MA2 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2-40; NERVE PROTEIN; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CHEMISTRY; CHI SQUARE DISTRIBUTION; DOWN REGULATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; PATHOLOGY; PREDICTIVE VALUE; UPREGULATION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, NEOPLASM; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHI-SQUARE DISTRIBUTION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM GRADING; NERVE TISSUE PROTEINS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 79959837064     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-59     Document Type: Article

References (22)

1. Chen EY, Tran A, Taho CJ, Birch CM, Crum CP, Hirsh MS. Histological 'progression' from low (LSIL) to high (HSIL) squamous intraepithelial lesion is an uncommon event and an indication for quality assurance review. Mod Pathol 2010, 23:1045-1051. 10.1038/modpathol.2010.85, 20473279.
2. Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P, Malamou-Mitsi V, Paraskevaidis E. P16INK4a immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treatment Reviews 2009, 35:210-220. 10.1016/j.ctrv.2008.10.005, 2784486, 19261387.
3. Marks A, Sutherland DR, Bailey D, Iglesias J, Law J, Lei M, Yeger H, Banerjee D, Baumal R. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumors. Br J Cancer 1999, 80:569-578. 10.1038/sj.bjc.6690393, 2362349, 10408868.
4. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's and a subset of angiosarcomas. Mod Pathol 2002, 15:434-440. 10.1038/modpathol.3880543, 11950918.
5. Fogt F, Zimmerman RL, Ross HM, Daly T, Gausas RE. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep 2004, 11:47-50.
6. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002, 82:1255-1257.
7. Chu AY, Litzky LA, Pasha TL, Acs G, Zhang PJ. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 2005, 18:105-110. 10.1038/modpathol.3800259, 15389250.
8. Dumoff KL, Chu C, Xu X, Pasha T, Zhang PJ, Acs G. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod Pathol 2005, 18:97-104. 10.1038/modpathol.3800269, 15467716.
9. Dijkstra MG, Heideman DA, de Roy SC, Rozendaal L, Berkhof J, van Krimpen K, van Groningen K, Snijders PJ, Meijer CJ, van Kemenade FJ. p16INK4a immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions. J Clin Pathol 2010, 63:972-977. 10.1136/jcp.2010.078634, 20924035.
10. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001, 92:276-284. 10.1002/ijc.1174, 11291057.
11. Bailey D, Baumal R, Law J, Sheldon K, Kannampuzha P, Stratis M, Kahn H, Marks A. Production of a monoclonal antibody specific for seminomas and dysgerminomas. Proc Natl Acad Sci USA 1986, 83:5291-5295. 10.1073/pnas.83.14.5291, 323937, 3523489.
12. Baumal R, Bailey D, Giwercman A, Skakkebaek N, Stratis M, Marks A. A novel maturation marker for human Sertoli cells. Int J Androl 1989, 12:354-359. 10.1111/j.1365-2605.1989.tb01324.x, 2687179.
13. Longatto-Filho A, Pinheiro C, Pereira SM, Etlinger D, Moreira MA, Jube LF, Queiroz GS, Baltazar F, Schmitt FC. Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix. Gynecol Oncol 2007, 107:45-51. 10.1016/j.ygyno.2007.05.029, 17604828.
14. Carraway KL, Hull SR. O-glycosylation pathway for mucin-type glycoproteins. Bioessays 1989, 10:117-121. 10.1002/bies.950100406, 2658987.
15. Lesuffleur T, Zweibaum A, Real FX. Mucins in normal and neoplastic human gastrointestinal tissues. Crit Rev Oncol Hematol 1994, 17:153-180. 10.1016/1040-8428(94)90053-1, 7865137.
16. Gendler SJ, Spicer AP. Epithelial mucin genes. Annu Rev Physiol 1995, 57:607-634. 10.1146/annurev.ph.57.030195.003135, 7778880.
17. Carraway KL, Perez A, Idris N, Jepson S, Arango M, Komatsu M, Haq B, Price-Schiavi SA, Zhang J, Carraway CA. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. Prog Nucleic Acid Res Mol Biol 2002, 71:149-185.
18. Wang JL, Zheng BY, Li XD, Angström T, Lindström MS, Wallin KL. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res 2004, 10:2407-2414. 10.1158/1078-0432.CCR-03-0242, 15073118.
19. Andersson S, Wangsa D, Flores-Staino C, Safari H, Mints M, Hjerpe A, Hagmar B, Johansson B. Expression of p16(INK4a) in relation to histopathology and viral load of 'high-risk' HPV types in cervical neoplastic lesions. Eur J Cancer 2006, 42:2815-2820. 10.1016/j.ejca.2006.06.023, 16973350.
20. Omori M, Hashi A, Nakazawa K, Yuminamochi T, Yamane T, Hirata S, Katoh R, Hoshi K. Estimation of prognoses for cervical intraepithelial neoplasia 2 by p16INK4a immunoexpression and high-risk HPV in situ hybridization signal types. Am J Clin Pathol 2007, 128:208-217. 10.1309/0UP5PJK9RYF7BPHM, 17638654.
21. Horn LC, Reichert A, Oster A, Arndal SF, Trunk MJ, Ridder R, Rassmussen OF, Bjelkenkrantz K, Christiansen P, Eck M, Lorey T, Skovlund VR, Ruediger T, Schneider V, Schmidt D. Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2008, 32:502-512. 10.1097/PAS.0b013e31815ac420, 18223479.
22. Bergeron C, Ordi J, Schmidt D, Trunk MJ, Keller T, Ridder R, . European CINtec Histology Study Group Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin Pathol 2010, 133:395-406. 10.1309/AJCPXSVCDZ3D5MZM, 20154278, European CINtec Histology Study Group.